Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis.
Enomoto S, Tamai H, Shingaki N, Mori Y, Moribata K, Shiraki T, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M. Enomoto S, et al. Among authors: moribata k. Hepatol Int. 2011 Jun;5(2):730-7. doi: 10.1007/s12072-010-9245-8. Epub 2011 Jan 9. Hepatol Int. 2011. PMID: 21484138 Free PMC article.
Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation.
Tamai H, Shingaki N, Shiraki T, Tukuda H, Mori Y, Moribata K, Enomoto S, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M. Tamai H, et al. Among authors: moribata k. Hepatol Res. 2011 Dec;41(12):1137-44. doi: 10.1111/j.1872-034X.2011.00879.x. Epub 2011 Sep 26. Hepatol Res. 2011. PMID: 21951330
Prediction of efficacy to pegylated interferon-α-2b plus ribavirin in patients with genotype 2 hepatitis C virus using viral response within 2 weeks.
Wada Y, Tamai H, Uno A, Kawashima A, Shingaki N, Mori Y, Moribata K, Miyata K, Higashi K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M. Wada Y, et al. Among authors: moribata k. Hepatol Res. 2014 Feb;44(2):179-86. doi: 10.1111/hepr.12101. Epub 2013 Mar 27. Hepatol Res. 2014. PMID: 23531032
Hypointense hepatocellular carcinomas on apparent diffusion coefficient mapping: Pathological features and metastatic recurrence after hepatectomy.
Mori Y, Tamai H, Shingaki N, Hayami S, Ueno M, Maeda Y, Moribata K, Deguchi H, Niwa T, Inoue I, Maekita T, Iguchi M, Kato J, Terada M, Yamaue H, Ichinose M. Mori Y, et al. Among authors: moribata k. Hepatol Res. 2016 Jun;46(7):634-41. doi: 10.1111/hepr.12598. Epub 2015 Nov 5. Hepatol Res. 2016. PMID: 26407147
44 results